Reflect Scientific, Inc. Receives U.S. Patent For Catalytic Inspection Method
Main Category: Pharma Industry / Biotech IndustryArticle Date: 28 Mar 2008 - 1:00 PDT
Reflect Scientific, Inc. (OTCBB: RSCF) announces that the Company has been issued another patent from the United States Patent Office. The patent discloses a unique method for inspecting an object having a planar face with surface variations.
Management believes that the intellectual property contained within the issued patent will enhance Miralogix's inspection instrumentation, thus offering more features and value to our customers.
Brian Smithgall of Image Labs International, a wholly owned subsidiary of Reflect Scientific, developed the technology described in this patent. The patent will join the intellectual property portfolio of Miralogix, a separate wholly owned subsidiary of the Company, and will enhance Miralogix's popular CatPro catalytic inspection platform.
"Miralogix continues its position in developing new instruments and related high-value services for catalytic inspection. We're pleased to demonstrate how our subsidiaries are actively working together to leverage dispersed assets to develop technology for the benefit of all operating units across Reflect Scientific," remarked John Hammerman, Business Operations Manager for Reflect Scientific.
About Image Labs International
Image Labs International is engaged in the design, development and manufacturing of scientific equipment in the areas of automated inspection, measurement and material handling. The company operates within dynamic capital equipment markets and has been listed on the INC 500 as one of America's fastest growing companies. Image Labs International is a wholly owned subsidiary of Reflect Scientific.
About Miralogix
Miralogix develops, manufactures and markets optical imaging systems and automated machine vision inspection tools. These products provide value added technological solutions to support a growing industry need in the area of automated inspection of environmental catalysts, in particular, those needed to address new regulatory standards for diesel emissions. Miralogix is a wholly owned subsidiary of Reflect Scientific.
About Reflect Scientific
Reflect Scientific and its subsidiaries provide diverse scientific products and services for the biotechnology, pharmaceutical and medical industries.
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
Reflect Scientific, Inc.
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2008 MediLexicon International Ltd |





